Navigation Links
Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture
Date:9/15/2010

ding physicians with a simple and cost-effective method of capturing of embolic particles during angioplasty procedures. Proteus is a one of its kind device to combine balloon angioplasty and embolic capture to receive FDA clearance, which was received in April 2010. The Proteus device is presently indicated for use in the lower limbs during Percutaneous Transluminal Angioplasty (PTA) procedures.

Proteus joins the new class of medical devices aimed at treating peripheral arterial disease (PAD), one of the fastest-growing segments in the worldwide interventional marketplace. An estimated 10 million patients suffer from PAD in the U.S. alone, of whom approximately 1,000,000 undergo a revascularization or amputation procedure each year. PTA procedures are a common treatment for peripheral artery disease for opening up the artery to improve blood flow. However, one potential complication of a PTA procedure is debris from the artery wall being disturbed during the procedure and floating through the blood stream. In the worst case this floating debris can totally occlude the artery and cause complete lack of circulation to the lower limb.

The Proteus device combines a standard angioplasty balloon with a feature that can capture the debris that maybe liberated during the PTA procedure. Proteus has the same characteristics as a standard angioplasty balloon but the embolic capture feature allows debris to be trapped within the balloon and removed as the physician removes the angioplasty balloon at the end of the PTA procedure.

"We believe that Proteus and Embolic Capture Angioplasty (ECA) represents a major advancement in the approach to angioplasty procedures. We are actively commercializing the Proteus in the U.S. via our direct sales force. In a relatively short time we are already active in over 15 hospitals in US and are very pleased with the acceptance of the device," said Doron Besser, President and CEO of Angioslide

Besser added, "This
'/>"/>

SOURCE Angioslide Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Genomic Health, Inc. (Nasdaq: ... conference call and webcast on Thursday, August 7 at 4:30 ... results.  The call and webcast will follow the release of ... Conference Call Details To access the live conference call on ... dial (877) 303-7208 from the United States ...
(Date:7/31/2014)... WASHINGTON , July 31, 2014 /PRNewswire/ ... the first pharmacy in the nation to earn ... leading health care accreditation organization that establishes quality ... and Longs Drug Store locations nationwide have earned ... 30 accreditation programs. Its Community Pharmacy Accreditation Program ...
(Date:7/31/2014)... LAWRENCEVILLE, N.J. , July 31, 2014  Celsion ... the Company will host a conference call to discuss ... EDT on Thursday, August 7, 2014. To participate in ... North America ) or 1-785-830-1924 (International/Toll) and ask ... (Conference Code: 8283269) to register ten minutes before the ...
Breaking Medicine Technology:Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 2CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 3Celsion Corporation to Hold Second Quarter 2014 Financial Results 2
... Helix Health, the first U.S.,stand-alone genomic medicine practice, is ... 1:00-2:30 PM EDT examining:, How Genomic Medicine ... To register, point your browser here, http://event.netbriefings.com/event/helixhealth/register.html ... States are diagnosed with cancer.,There is a growing number ...
... Scientists Refused To Do,Illustrates Vaccine Program And Mercury ... Findings released Friday,showed that infant monkeys given ... Academy of Pediatrics (AAP) exhibited autism-like,symptoms. Lead investigator ... presented study results at the International Meeting for,Autism ...
Cached Medicine Technology:Join NPR's David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer 2Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists 2
(Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... is a major factor driving the global geriatric care ... demand outstrips the supply of these services across the ... family forming a home care agency to few large ... that the market is underserved and is also highly ...
(Date:7/31/2014)... During the winter of 1944, the Nazis blocked food ... widespread famine and devastation. The impact of starvation on ... "experiments" changes resulting from external rather than genetic ... to hardship could be inherited. The underlying mechanism, however, ... recently in the journal Cell , Dr. Oded ...
(Date:7/31/2014)... The “Nucleic Acid Isolation and Purification Market ... based), Consumables & Instruments, by Application (Plasmid DNA ... - Global Forecasts to 2018” provides a detailed ... current market trends, and strategies impacting the global ... the estimates and forecasts of the revenue and ...
(Date:7/31/2014)... Albany, NY (PRWEB) July 31, 2014 ... Review, H2 2014, provides an overview of the ... comprehensive information on the therapeutic development for Brain ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ...
(Date:7/31/2014)... Calif., July 31, 2014 Much of the liver,s ... own body clock and UC Irvine researchers have ... , The study, published online today in Cell ... over metabolism and points the way to more focused ... as obesity and diabetes. , Paolo Sassone-Corsi, UCI,s Donald ...
Breaking Medicine News(10 mins):Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 2Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 4Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 5Health News:The 'memory' of starvation is in your genes 2Health News:The 'memory' of starvation is in your genes 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 4Health News:Strict genomic partitioning by biological clock separates key metabolic functions 2
... HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay News) ... performance, but not necessarily in autistic children, a new ... spelling and math abilities of 30, "high-functioning" 9-year-old autistic ... parental and teacher reports at ages 6 and 9. ...
... cells (CSCs), the aggressive cells thought to be resistant to ... estrogen via a pathway that mirrors normal stem cell development. ... of breast CSCs, a finding that suggests a new drug ... the Proceedings of the National Academy of Sciences ...
... Exercising to music reduces the risk of falls among elderly ... adults, mostly women, average age 75.5 years, who were at ... intervention group that did a music-based multitask exercise program or ... six months, the participants switched groups for the next six ...
... , TUESDAY, Nov. 23 (HealthDay News) -- Implantable ... while preventing sudden death among heart failure patients ... real-world situations as they are in controlled study ... based on an analysis of nearly 186,000 patients ...
... the dangers of excessive fructose in diet. A new review ... of the American Society of Nephrology ( JASN ) ... Richard J. Johnson, MD and Takahiko Nakagawa, MD (Division ... concise overview of recent clinical and experimental studies to understand ...
... 22 (HealthDay News) -- Deaths from congenital heart defects in ... continuing a decades-long decline, a new study finds. Congenital ... These include a variety of conditions that range from mild ... as irregular heartbeats, congestive heart failure and high blood pressure ...
Cached Medicine News:Health News:For Autistic Kids, IQ May Not Predict School Achievement 2Health News:For Autistic Kids, IQ May Not Predict School Achievement 3Health News:Discovery halts breast cancer stem cells 2Health News:Practicing Moving to Music May Help Elderly Avoid Falls 2Health News: Implanted Heart Devices Have 'Real-World' Benefits: Study 2Health News: Implanted Heart Devices Have 'Real-World' Benefits: Study 3Health News:Deaths From Congenital Heart Defects on the Decline 2
... (TSH) is a 32 kDa glycoprotein secreted ... pituitary gland [1]. The structure of human ... pituitary and placental gonadotropins, consisting of an ... these hormones and a unique beta-subunit, which ...
... (T4) is the primary active hormone synthesized ... gland [1]. T4 is synthesized via a ... by the follicular cells, (ii) iodination of ... to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT ...
... produced primarily by 5-monodeioination of thyroxine (T4) ... T3 production occurs at a rate which ... Release of T3 from the thyroid gland ... compared to 80-100 micrograms/day for T4. In ...
... protein-3 (IGFBP-3) is the main binding protein for ... component of the ~150 kDa ternary complex. This ... or IGF-II and ALS, allowing IGFBP-3, along with ... The molar concentration of IGFBP-3 in normal serum ...
Medicine Products: